Neuronal AMPA receptors autoinactivate at high concentrations of glutamate, i.e., the current declines at glutamate concentrations above 10-100 mM. The mechanisms underlying this phenomenon are unclear. Stargazin-like TARPs are AMPA receptor auxiliary subunits that modulate receptor trafficking and channel properties. Here, we found that neuronal AMPA receptors and recombinant AMPA receptors coexpressed with stargazin autoinactivate at high concentrations of glutamate, whereas recombinant AMPA receptors expressed alone do not. The reduction of currents at high glutamate concentrations is not associated with a reduction of AMPA receptor number, but rather with the loss of stargazin-associated allosteric modulation of channel gating. We show that receptor desensitization promotes the dissociation of TARP-AMPA receptor complexes in a few milliseconds. This dissociation mechanism contributes to synaptic short-term modulation. The results demonstrate a mechanism for dynamic regulation of AMPA receptor activity to tune synaptic strength.
INTRODUCTION
Glutamate is the most abundant excitatory neurotransmitter in the brain and acts on three classes of ionotropic glutamate receptors (AMPA, NMDA, and kainate), which function distinctly (Dingledine et al., 1999; Hollmann and Heinemann, 1994; Seeburg, 1993) . AMPA receptors mediate fast synaptic transmission, whereas NMDA receptors and kainate receptors are involved in synaptic plasticity (Kandel, 2001; Lerma, 2006; Malenka and Nicoll, 1999; Nicoll and Schmitz, 2005) . Together, these three classes of glutamate receptors control and modulate neural circuits in the brain that underlie aspects of cognitive function.
AMPA receptors are hetero-oligomers composed of four subunits, GluR1-4 (Hollmann and Heinemann, 1994; Seeburg, 1993) , each of which is alternatively spliced to yield two isoforms (flip and flop) (Sommer et al., 1990) . Channels composed of different AMPA receptor subunits display quantitative differences in the kinetics of deactivation (channel closure upon glutamate removal) and desensitization (channel closure during continuous exposure to glutamate) (Jonas and Spruston, 1994) , and the subunit composition of AMPA receptors plays a major role in controlling the decay of EPSCs. Although the rules that determine the trafficking of heteromeric AMPA receptors remain uncertain, the subunit composition of AMPA receptors also influences the number of synaptic AMPA receptors under basal and activity-dependent conditions (Barry and Ziff, 2002; Malinow and Malenka, 2002; Sheng and Kim, 2002; Song and Huganir, 2002) .
The transmembrane AMPA receptor regulatory proteins (TARPs) are auxiliary subunits of AMPA receptors (Nicoll et al., 2006; Ziff, 2007) . TARPs consist of four typical isoforms (stargazin/g-2, g-3, g-4, g-8) and one atypical isoform (g-7), which each show distinct expression patterns in the brain (Fukaya et al., 2005; Kato et al., 2007; Tomita et al., 2003) and are evolutionally conserved (Walker et al., 2006) . TARPs bind to AMPA receptors (Fukata et al., 2005; Nakagawa et al., 2005; Tomita et al., 2003; Vandenberghe et al., 2005) and modulate both their trafficking and channel properties (Chen et al., 2000; Kott et al., 2007; Priel et al., 2005; Tomita et al., 2005a Tomita et al., , 2004 Turetsky et al., 2005; Yamazaki et al., 2004) . Mice in which the stargazin/g-2 gene is disrupted (stargazer) show loss of AMPA receptor activity in cerebellar granule cells (Chen et al., 2000; Hashimoto et al., 1999) . In addition, TARP g-8 knockout mice have altered AMPA receptor trafficking and AMPA receptor activity in the hippocampus (Fukaya et al., 2006; Rouach et al., 2005) . TARPs also control EPSC kinetics through their first extracellular loop (Cho et al., 2007; Milstein et al., 2007; Tomita et al., 2005a) .
Neuronal AMPA receptors have different properties from recombinant AMPA receptors. For example, neuronal AMPA receptors respond to kainate better than glutamate, whereas recombinant AMPA receptors respond to glutamate better than kainate. This discrepancy has been resolved by coexpressing AMPA receptors with TARPs in recombinant systems, which results in a robust enhancement of kainate efficacy (Kott et al., 2007; Tomita et al., 2005a; Turetsky et al., 2005) . Furthermore, glutamate-evoked steady-state current from cells expressing recombinant AMPA receptors have typical sigmoid concentrationresponse curves (Hollmann and Heinemann, 1994; Robert and Howe, 2003) . In contrast, the responses from AMPA receptors in the avian cochlear nucleus and oocytes injected with polyA RNA from the rat cerebral cortex show a bell-shaped concentrationresponse, where the amplitude of the steady-state current declines at glutamate concentrations above 100 mM (Geoffroy et al., 1991; Raman and Trussell, 1992; Vlachova et al., 1987) . The mechanisms that give rise to these different concentration-response relationships remain unclear.
In this study, we have examined the molecular mechanisms underlying the autoinactivation of neuronal AMPA receptors. We found that AMPA receptors in mouse cerebellar granule cells, like the avian cochlear nucleus, also display reduced steady-state currents at glutamate concentrations above 100 mM, demonstrating that this is also a feature of mammalian receptors in neurons. Whereas expression of AMPA receptors alone in Xenopus laevis oocytes did not result in autoinactivated bell-shaped curves, such curves were obtained upon coexpression of AMPA receptors with stargazin. Although stargazin modulates all AMPA receptor subunits, the magnitude of the stargazin-related reductions in the amplitude of currents evoked by high concentrations of glutamate depended on subunit composition and differed for flip and flop splicing isoforms of AMPA receptors. Our results show that high concentrations of glutamate promote the dissociation of stargazin from AMPA receptors, an effect that occurs within a few milliseconds after receptor desensitization and requires the cytoplasmic domain of AMPA receptors. Furthermore, we found that this autoinactivation mechanism contributes to short-term modulation of AMPA receptor activity at synapses. The novel mechanism described here could tune synaptic transmission upon neuronal activation or under conditions where ambient levels of glutamate are elevated.
RESULTS

Stargazin Modulation of AMPA Receptor Function Depends on Glutamate Concentration
Previous studies have shown that AMPA receptors have a bellshaped glutamate concentration-response curve in neurons from the avian cochlear nucleus, where the amplitude of the steady-state current declined at glutamate concentrations above 100 mM, so called ''autoinactivation'' (Raman and Trussell, 1992; Vlachova et al., 1987) . To test whether mammalian AMPA receptors show similar characteristics, we measured glutamateevoked whole-cell currents in mouse cerebellar granule cells. Glutamate was applied in the continuous presence of cyclothiazide (CTZ), which selectively reduces desensitization of AMPA receptor flip splicing isoforms (and to a lesser extent flop isoforms; Partin et al., 1994) . Under these conditions, currents were detected at glutamate concentrations of 3 mM. At concentrations of 50 mM and below, the currents did not decline during 5 s applications. At glutamate concentrations of 100 mM and above, the initial amplitude of the response faded ( Figure 1A) . Plots of the mean initial amplitude of the currents against glutamate concentration gave typical sigmoid concentrationresponse relationships and EC 50 values of approximately 20 mM (data not shown). Whereas the peak amplitudes of whole-cell currents evoked by 1000 mM glutamate were larger than those by 50 mM glutamate (ratio: 1.41 ± 0.07, n = 12), steady-state currents were consistently and significantly smaller than the corresponding currents obtained with 50 mM glutamate ( Figures 1A and 1D) .
To examine the mechanisms that underlie the reduction in the amplitude of steady-state AMPA-receptor currents at near-saturating concentrations of glutamate, we used Xenopus laevis oocytes as a model system . In oocytes expressing the flop isoform of the GluR1 AMPA-receptor subunit (GluR1o) alone, the steady-state currents evoked by 1000 mM glutamate were larger than the currents evoked by 5 mM glutamate or 10 mM kainate ( Figures 1B and 1D ). Because native AMPA receptors in cerebellar granule cells contain the prototypical TARP stargazin (Chen et al., 2000) , we coexpressed stargazin and GluR1o in oocytes to better mimic native receptors. In contrast to GluR1o alone, oocytes coexpressing GluR1o and stargazin gave larger responses to 5 mM glutamate than to 1000 mM glutamate ( Figures 1C and 1D ). Similar effects of stargazin coexpression were seen for the GluR1 flip isoform (GluR1i; Figure 1D ), and stargazin enhanced kainate-evoked currents from oocytes expressing both the flip and flop isoforms of GluR1 ( Figures 1C and 1E ), as reported previously (Kott et al., 2007; Tomita et al., 2005a; Turetsky et al., 2005) . We also found that stargazin decreased significantly the steady-state current ratio for 1000 mM and 5 mM glutamate. This effect of stargazin was seen without calcium in the extracellular recording solution ( Figure 1F ) and was reproduced for other AMPA receptor isoforms, although the responses to 1000 mM glutamate were still larger than those to 5 mM for the GluR2 flip isoform ( Figure 1G ). The results suggest that whether neuronal AMPA receptors show autoinactivated bell-shaped concentration-response curves may depend on the repertoire of AMPA receptor isoforms expressed. However, for all AMPA receptor subunits examined, modulation of gating behavior by stargazin depends on glutamate concentration.
Stargazin-Mediated Concentration-Dependent Modulation of AMPA Receptors Is Not Associated with a Change in Receptor Number
It is well established that stargazin is involved in AMPA receptor trafficking (Nicoll et al., 2006; Ziff, 2007) . We therefore asked whether the reduction in current amplitudes at high glutamate concentrations was due to a reduction in the number of AMPA receptors at the cell surface. In oocytes coexpressing extracellularly HA-epitope tagged GluR1 and stargazin, we measured the surface expression of AMPA receptors in the absence or continuous presence of glutamate using chemiluminescence assays (Tomita et al., 2005a) . The surface expression of HA-GluR1i was not altered by glutamate application (Figure 2A ). We then correlated the glutamate-evoked current at two different glutamate concentrations (10 mM and 500 mM) to the amount of receptors on the cell surface in the presence or absence of stargazin (Figures 2B and 2C) . This allowed us to compare the size of glutamate-evoked currents with and without stargazin in oocytes with the same number of surface receptors. For both GluR1 flip and flop receptors, coexpression of stargazin increased the amplitude of currents evoked by 10 mM glutamate but not 500 mM glutamate (Figures 2B and 2C ).
Concentration-Dependent Modulation of AMPA Receptors by Stargazin Requires the Cytoplasmic Domain of AMPA Receptors
To identify the AMPA receptor domains required for the reduced stargazin-mediated modulation of steady-state currents at high concentrations of glutamate, we constructed chimeric receptors in which regions of the AMPA receptor GluR1o and the kainate receptor GluR6 (which does not interact with stargazin Tomita et al., 2007a) ) were exchanged ( Figure 3A) . We coexpressed the chimeras with stargazin in oocytes and measured the ratio of currents evoked by 1000 mM and 5 mM glutamate. This ratio was less than 1 for each of the chimeras except for receptors in which the cytoplasmic tail of GluR1 was replaced with the corresponding domain from GluR6 (6Cyto). The 6Cyto chimera gave 1000 mM/5 mM ratios that were not significantly different from the corresponding ratios obtained for GluR1o receptors without stargazin coexpression ( Figure 3A) . Furthermore, replacing the GluR1 ligand-binding domain with that from GluR6 (6S1S2) resulted in robust reduction of the ratio of currents evoked by 1000 mM and 5 mM glutamate in the presence of stargazin ( Figure 3A) , whereas in the absence of stargazin both 6S1S2 and 6Cyto gave larger responses to 1000 mM glutamate than to 5 mM glutamate. Stargazin increased both the kainate efficacy and the surface expression of the 6Cyto chimera, demonstrating that the 6Cyto chimera interacts with stargazin ( Figures 3B and 3C ). Similar effects were observed for a chimeric construct in which the flip isoform of GluR1 was used (6Cyto(R1i); Figure 3D ). In addition, deletion of the N-terminal domain of the AMPA receptors (DNTD) did not alter the effects of stargazin on kainate efficacy (Tomita et al., 2007b) nor the concentration-dependent modulation of glutamate responses ( Figure S1 ). The results with the 6Cyto chimeras show that the cytoplasmic tail of GluR1 is required for glutamate concentration dependent modulation of stargazin-mediated AMPA receptor activity, and the results with the 6S1S2 chimera suggest that this modulation is influenced by conformational changes that occur at the level of the ligand-binding domain.
Glutamate Promotes the Dissociation of Stargazin from AMPA Receptors
Because the effect of stargazin to potentiate AMPA receptor activity was reduced at high concentrations of glutamate ( Figures 2B and 2C ), we hypothesized that stargazin does not interact with AMPA receptors under these conditions. Indeed, previous coimmunoprecipitation experiments demonstrated that prolonged exposure of purified TARP g-3/AMPA receptor complexes to 100 mM glutamate reduced the association of the related TARP isoform g-3 with native AMPA receptors (Tomita et al., 2004) .
To test the hypothesis that glutamate promotes the dissociation of stargazin, stargazin/GluR1 complexes were immunopurified with anti-stargazin antibody from oocytes coexpressing GluR1 and stargazin, followed by the addition of glutamate to (A) Glutamate-evoked whole-cell currents were measured in cultured mouse cerebellar granule cells. The steady-state current evoked by 50 mM glutamate was larger than that of 1000 mM glutamate in the presence of cyclothiazide (100 mM).
(B and C) Agonist-evoked steady-state currents were recorded in oocytes injected with GluR1 flop (GluR1o) alone or together with stargazin (STG). Steady-state currents evoked by 1000 mM glutamate were larger than those by 5 mM glutamate or 10 mM kainate (KA) in oocytes expressing GluR1o alone (20 ng) (B). In contrast, stargazin enhances the response to kainate relative to glutamate. Furthermore, steady-state currents evoked by 1000 mM glutamate were smaller than those by 5 mM glutamate in oocytes expressed GluR1o with stargazin (0.2 ng each) (C). (D) Neurons and oocytes coexpressing GluR1 with stargazin have smaller steady-state currents evoked by 1000 mM glutamate than by 50 mM (n = 12) and 5 mM glutamate (n = 5-7), respectively. (E) Stargazin modulates the KA efficacy of GluR1 (n = 6, 7). (F) Stargazin modulates the ratio of currents evoked by 1000 mM and 5 mM without calcium in the extracellular recording solution. 1.5 mM calcium chloride are replaced with 0.5 mM barium chloride/1.0 mM magnesium chloride (n = 5). (G) Stargazin decreases the steady-state current ratio evoked by 1000 and 5 mM glutamate in oocytes expressing the AMPA receptor isoform GluR2 R or Q editing forms, or GluR1/GluR2 heteromers (n = 6, 7). ND indicates that agonist-evoked currents were undetectable. Data represent the mean ± SEM from the indicated number of experiments. the immunocomplexes. We found that glutamate caused the dissociation of GluR1 AMPA receptors from stargazin, an effect that was blocked by the competitive AMPA-receptor antagonist CNQX ( Figure 4A ). Similar results were obtained from brain homogenates ( Figure S2A ). Importantly, the same glutamate treatment of immunocomplexes containing stargazin and 6Cyto did not cause dissociation ( Figure 4A ), supporting the idea that glutamate-induced dissociation of stargazin is responsible for the reduced steady-state currents seen at high concentrations of glutamate. The glutamate-mediated dissociation of stargazin and GluR1 depended on glutamate concentration, with a mean effective concentration of 16 mM ( Figure 4B ). Since AMPA receptor currents evoked by kainate did not show bellshaped concentration-response curves when AMPA receptors were coexpressed with stargazin (Tomita et al., 2007b) , we also examined the effect of kainate in coimmunoprecipitation assays and found that kainate did not result in the dissociation of GluR1 and stargazin ( Figures S2B and S2C ).
The dissociation curve in Figure 4B allowed us to calculate the fraction of stargazin bound to AMPA receptors at different concentrations of glutamate and to simulate glutamate concentration-response curves for AMPA receptors when they are coexpressed with stargazin ( Figure 4C ). Recombinant GluR1o channels showed a typical sigmoid curve, with an EC 50 of about 10 mM and a Hill coefficient close to 1 (Figures 4C and 4D, inset) . Stargazin coexpression decreases the glutamate EC 50 value for steady-state currents about 5-fold (Kott et al., 2007; Priel et al., 2005; Tomita et al., 2005a; Turetsky et al., 2005; Yamazaki et al., 2004) . After normalization for receptor number, the currents evoked by 10 mM glutamate were increased by a factor of about 4 ( Figures 2B and 2C ). These results can be used to construct a hypothetical concentration-response curve for GluR1o channels when coexpressed with stargazin ( Figure 4D , inset). The sum of the two curves in Figure 4D (weighted by the fraction of channels with and without bound stargazin, Figure 4B ) is similar to the curves obtained experimentally from oocytes coexpressing GluR1o and stargazin ( Figure 4C ).
Preventing Stargazin Dissociation Enhances Steady-State Currents Evoked by High Concentrations of Glutamate
If stargazin dissociation gives rise to glutamate-dependent modulation of AMPA receptors, then preventing dissociation of stargazin and AMPA receptors should eliminate it. To test this prediction directly, we generated GluR1-stargazin tandem proteins in which the N terminus of stargazin was directly fused to the C-terminal end of GluR1 ( Figure 5A ). Oocytes injected with the GluR1o-stargazin tandem construct responded to low concentrations of glutamate similarly to oocytes coinjected with GluR1o and stargazin ( Figure 5B ). The efficacy of kainate was also enhanced to an extent similar to that when GluR1o and stargazin were coexpressed as separate proteins ( Figure 5C ). Coexpression of stargazin with the GluR1o-stargazin tandem protein did not further enhance glutamate-evoked currents or kainate efficacy ( Figures 5B and 5C ). The GluR1o-stargazin tandem therefore forms functional channels that exhibit signature characteristics of stargazin's effects on AMPA receptor properties. Importantly, steady-state responses of the GluR1o-stargazin tandem receptors did not decline at high glutamate concentrations ( Figure 5D ), suggesting that the decline in coexpression experiments is due to the dissociation of stargazin from AMPA receptors.
To analyze the kinetics of stargazin dissociation from AMPA receptors, we conducted fast application experiments on outside-out patches from tsA201 cells transfected with GluR1i, GluR1i and stargazin, or a GluR1i-stargazin tandem construct. Typical currents recorded in the three types of patch in response to 100 ms applications of 10 mM glutamate are shown in Figure 6A , where the peak amplitudes have been normalized to allow comparison of the relative steady-state currents. Similar to our results in oocytes ( Figure 5D ), steady-state currents (A) Oocytes were injected with extracellular HA epitope-tagged GluR1 flip (HAGluR1i) and stargazin transcripts, and the surface expression of HA-GluR1i was quantified by chemiluminescence (n = 6). The application of 1000 mM glutamate did not alter the surface expression of HA-GluR1i. Signal from oocytes injected with nontagged GluR1 and stargazin was accounted as background. (B) Surface expression of HA-GluR1i (n = 9) and steady-state currents evoked by 10 mM and 500 mM glutamate (n = 5) were measured in parallel in oocytes injected with different amounts of HA-GluR1i cRNA and stargazin (STG). Stargazin modulates AMPA receptor function evoked by 10 mM glutamate, but not by 500 mM glutamate. (C) The experiments in (B) were repeated in oocytes expressing GluR1o. Data represent the mean ± SEM from the indicated number of experiments.
were larger for the GluR1i-stargazin tandem (7.8% ± 0.7% of the peak, n = 6) than they were for GluR1i with stargazin (4.0% ± 0.7%, n = 5; p < 0.005) ( Figures 6A and 6B ). In contrast, the effect of stargazin to slow desensitization was similar in the GluR1i-stargazin tandem, as can be seen in the inset to Figure 6A where the decays of the two scaled currents are virtually identical. Biexponential fits to the decays of the two types of responses gave similar values for both the time constants of the fast and slow components (t f and t s = 2.5 ± 0.7 ms and 10.2 ± 1.5 ms, GluR1i + stargazin; 3.0 ± 0.4 ms and 10.7 ± 1.4, GluR1i-stargazin), as well as the relative amplitude of the slow component (A s = 37.3% ± 5.7% versus 32.7% ± 3.3%) ( Figure 6B ).
Comparison of other receptor properties indicated that steady-state currents were selectively enhanced in the GluR1i-stargazin tandem protein. The kinetics of deactivation was not different for GluR1i with stargazin and the GluR1i-stargazin tandem. Hill-type fits to concentration-response data for peak currents gave EC 50 values for GluR1i + stargazin (570 mM) and GluR1i-stargazin (607 mM) that were similar to the corresponding value reported for GluR1i alone (717 mM; Robert and Howe, 2003) ; and, unlike steady-state currents, peak currents did not decline at high glutamate concentrations in any of the three conditions. Measurements of peak current amplitudes with and without CTZ (an indication of open probability [P open ] at the Oocytes were injected with 20 ng GluR1 flop (GluR1o) cRNA or GluR6 cRNA. Stargazin (STG) (0.1 ng) was injected with GluR1o and GluR1o chimeric constructs (0.2 ng) as indicated. Steady-state currents evoked by 5 mM or 1000 mM glutamate were measured by TEVC recording (n = 9-11). (A) Replacing the cytoplasmic domain of GluR1o with that of GluR6 (6Cyto) disrupted the concentration-dependent modulation of AMPA receptor function by stargazin, whereas replacing the ligand-binding domain (S1S2) of GluR1 with that of GluR6 (6S1S2) enhanced it. Green and blue asterisks indicate a significant difference compared with GluR1o with STG and GluR1 alone, respectively. Stargazin increases kainate efficacy (B) and the surface expression (C) of both GluR1o and 6Cyto as measured by chemiluminescence (n = 9) and TEVC recording (n = 9-13). (D) Replacing the cytoplasmic domain of GluR1 flip (GluR1i) with that of GluR6 [6Cyto(R1i)] also disrupted the concentration-dependent modulation of AMPA receptor function by stargazin (n = 5, 6). Data represent the mean ± SEM from the indicated number of experiments. peak response; Cho et al., 2007) gave similar results for GluR1i with stargazin and the GluR1i-stargazin tandem. The ratio of the peak currents with and without CTZ was 1.28 ± 0.04 (n = 5) for the tandem receptor protein and 1.32 ± 0.05 (n = 5) for GluR1i coexpressed with stargazin. Both values were significantly smaller than the ratio obtained for GluR1i alone (1.54 ± 0.02, n = 4; p < 0.05, one-way ANOVA). The 10%-90% rise times of the currents without CTZ in these experiments were similar for all three receptor types (GluR1i: 282 ± 44 ms; GluR1i + stargazin, 330 ± 44 ms; GluR1i-stargazin, 250 ± 36 ms).
The results show that the primary difference between GluR1i-stargazin tandem receptors and the receptors in the GluR1i with stargazin coexpression experiments is the amplitude of the steady-state currents during sustained applications of glutamate. The results therefore imply that receptor desensitization promotes the dissociation of stargazin/AMPA receptor complexes and that the difference between the currents seen for tandem receptors and the receptors in the GluR1i/stargazin coexpression experiments ( Figure 6A) reflects the rate at which stargazin dissociates. We therefore averaged the glutamateevoked currents for GluR1i with stargazin and subtracted the mean waveform from the corresponding mean for GluR1i-stargazin receptors (after scaling the currents to have the same peak amplitude). The resultant difference current is shown in Figure 6C . The difference current develops exponentially with a time constant of 0.65 ms. Similar results were also obtained with GluR4i-stargazin tandem receptors ( Figure S3 ).
The effect of stargazin to speed recovery from desensitization (Priel et al., 2005) contributes to stargazin's enhancement of steady-state currents. We therefore compared recovery in twopulse experiments for GluR1i with stargazin and the GluR1i-stargazin tandem ( Figure 6D ). At brief intervals the recovery curves were similar. At intervals longer than 40 ms (where recovery was about one-third complete), recovery was slower in the coexpression experiments, suggesting that at these longer intervals some of the receptors that recover from desensitization no longer have stargazin associated with them. Comparison of recovery from desensitization for GluR4i with stargazin and the GluR4i-stargazin tandem supported a similar conclusion.
If it is desensitization that promotes the dissociation of stargazin, then the concentration dependence of stargazin dissociation and desensitization should be similar. One consistent effect of stargazin and other TARPs is to markedly enhance the slow component evident in deactivation decays (Cho et al., 2007; Milstein et al., 2007; Zhang et al., 2006) . Therefore if steady-state desensitization promotes the dissociation of stargazin, it should reduce stargazin enhancement of the amplitude of the slow component of deactivation. We therefore measured receptor deactivation in the continuous presence of 8 mM glutamate for GluR4i alone, GluR4i coexpressed with stargazin, and GluR4i-stargazin tandem receptors. As expected, the presence of 8 mM glutamate reduced the size of the peak currents evoked by 2 ms applications of 10 mM glutamate by approximately 50% (Robert and Howe, 2003) . Both coexpression of stargazin (C) The GluR1o-stargazin tandem protein modulates kainate efficacy to a similar extent as GluR1o and stargazin. The coexpression of STG with the GluR1o-stargazin tandem protein did not produce any additional enhancement of the response. (D) In contrast to receptors expressed in response to the coexpression of GluR1o and stargazin, the GluR1o-stargazin tandem protein did not show a reduction in current amplitudes at high glutamate concentrations. Coexpression of stargazin had no effect on the concentration-response behavior of GluR1o-stargazin receptors. Data represent the mean ± SEM (n = 5, 6).
and the GluR4i-stargazin tandem increased the amplitude of the slow component of deactivation under control conditions, and pre-exposure of the receptors to 8 mM glutamate reduced the relative amplitude of this component in the coexpression experiments but not for GluR4i-stargazin tandem receptors ( Figures  6E and 6F) . The results are consistent with the conclusion that desensitization promotes the dissociation of stargazin from AMPA receptors.
Preventing Stargazin Dissociation Alters Short-Term Modulation of Synaptic Transmission
Our fast application results indicate that glutamate-mediated dissociation of stargazin and AMPA receptors occurs within a few milliseconds, suggesting that this mechanism might contribute to basal synaptic transmission and short-term modulation of synaptic transmission. To examine possible roles of stargazin dissociation in synaptic transmission under basal conditions, we examined the effects of stargazin dissociation on basal synaptic transmission using cerebellar granule cell cultures from stargazer mice, which lack functional AMPA receptors (Chen et al., 2000; Cho et al., 2007; Milstein et al., 2007) . We overexpressed GFP alone, stargazin/GluR4i/GFP, or GluR4i-stargazin tandem/GFP in stargazer cerebellar granule cells and measured the amplitude and kinetics of spontaneous EPSCs from GFP positive neurons. As previously shown, we did not observe EPSCs in neurons transfected with GFP alone (n = 4). Each trace is the mean of 10 to 20 trials from individual patches. The currents were scaled so the peak amplitudes were the same (individual peak currents were 1.04-1.71 nA). The inset shows the decays of the currents scaled to the same amplitude after subtracting the respective steady-state currents to compare better the respective rates of desensitization. Note that in the inset the record for GluR1i + stargazin (green) and the record for the GluR1i-stargazin tandem (black) are virtually identical. (B) Weighted time constants (left) and steady-state currents (right) obtained from biexponential fits to the decays of currents (n = 5-6).
(C) Current obtained by subtracting the mean response for GluR1i and stargazin from the mean response for the GluR1i-stargazin tandem (data from all patches were averaged and the peak amplitudes were scaled as in panel [A] ). The inset shows the first 10 ms of the difference current, which decayed monoexponentially (tau = 0.65 ms).
(D) Data for recovery from desensitization obtained from two-pulse protocols (n = 5-6). Smooth curves are double Hodgkin-Huxley fits (Zhang et al., 2006) . Stargazin speeds recovery (relative to GluR1i alone) and the rates of recovery for GluR1i with stargazin and the GluR1i-stargazin tandem are similar for interpulse intervals less than 40 ms. (E and F) Deactivation protocols (10 mM glutamate for 2 ms) in the absence (black) and continuous presence of 8 mM glutamate (red). The presence of 8 mM glutamate reduced the peak current by about 50% and the pairs of records in each patch have been scaled so that the deactivation decays have the same amplitude. The decays were fitted with biexponential functions and the slow component of decay from these fits is shown for each record (dotted curves). On the other hand, we observed frequent EPSCs in neurons expressing stargazin/GluR4i/GFP or GluR4i-stargazin tandem/ GFP (n = 6), suggesting that both receptors are incorporated into synapses. The decays and amplitude of the EPSCs were similar for stargazin/GluR4i and GluR4i-stargazin tandem-transfected cells, suggesting that all AMPA receptors interact with stargazin under basal conditions in cerebellar granule cells ( Figures 7A and 7B ).
Next we examined whether stargazin dissociation plays a role in short-term modulation of synaptic transmission. We first attempted to find paired neurons with GFP transfected cerebellar granule cells. However, the high density of the cultured neurons and the low number of synapses prevented us from finding synaptically connected neurons. We therefore turned to hippocampal cultures, which have been used successfully for paired recordings. We overexpressed GFP with stargazin/GluR4i or the GluR4i-stargazin tandem in hippocampal cultured neurons. Simultaneous whole-cell recordings were made from a GFP-positive and neighboring neurons. In nontransfected neurons and neurons expressing stargazin and GluR4i, we observed paired pulse depression when EPSCs were evoked at an interval of 20 ms ( Figure 7D ). The ratio of the peak amplitudes of the second and first EPSC in neurons expressing stargazin and GluR4i was 0.78 ± 0.05 ( Figure 7E ). In contrast, we observed paired pulse facilitation in neurons expressing the GluR4i-stargazin tandem receptor ( Figures 7D and 7E) , with a paired pulse ratio of 1.41 ± 0.19. The results suggest that stargazin dissociation contributes to short-term modulation of synaptic transmission.
DISCUSSION
This study demonstrates that stargazin modulation of AMPA receptor activity varies with glutamate concentration. The reduced stargazin modulation at high concentrations of glutamate persisted when current amplitudes were normalized for potential differences in receptor number, demonstrating that it does not result from glutamate-induced receptor internalization or modulation of stargazin's known effects on AMPA receptor trafficking. The glutamate-dependent modulation of current amplitude requires the cytoplasmic domain of AMPA receptors and appears to result from the rapid dissociation of stargazin after receptor desensitization. The dynamic nature of stargazin regulation of AMPA receptor function allows stargazin to play a central role in short-term modulation of synaptic transmission.
Glutamate Concentration-Dependent Responses of AMPA Receptors in Different Types of Neurons
We show here that AMPA receptors in mouse cerebellar granule cells and recombinant AMPA receptors coexpressed with stargazin show autoinactivated concentration-response behavior similar to that described previously for AMPA receptors in avian neurons (Raman and Trussell, 1992; Vlachova et al., 1987) . However, it has been reported that AMPA receptors in rat hippocampal pyramidal cells have a sigmoid concentration curve response to glutamate (Patneau and Mayer, 1991) . One explanation for these different results is that AMPA receptors in the hippocampus lack TARPs (TARPless AMPA receptors). However, TARP g-8 knockout mice show a loss of surface AMPA receptor activity in the hippocampus (Rouach et al., 2005) , indicating that most surface AMPA receptors in the hippocampus interact with TARPs (TARPin AMPA receptors).
Another possible explanation for the different concentrationresponse relationships is that AMPA receptors in the hippocampus are composed of different subunits than receptors (D and E) Whole-cell paired recordings from primary cultured hippocampal neurons. Neurons were transfected with cDNAs encoding GFP alone, GFP with GluR4i and stargazin, GFP with GluR4i-stargazin tandem. Transfected neurons were identified by GFP expression. Putative pairs of morphologically connected neurons were identified visually and both neurons were patched simultaneously. Once synaptic connectivity was confirmed, pairs of 1 ms jumps À70 mV to + 20 mV were applied to the presynaptic neuron at an interval of 20 ms. Neurons expressing GFP alone (MOCK) and with GluR4i and stargazin showed paired-pulse depression, whereas paired-pulse facilitation was observed in neurons expressing GFP and the GluR4i-stargazin tandem (n = 4-6). (**p < 0.01, one-way ANOVA). The evoked EPSCs were blocked by the addition of the AMPA receptor antagonist CNQX (100mM, red traces in [D] ). All data represent the mean ± SEM. from other tissues. Stargazin modulated the concentrationdependent response of all AMPA receptors ( Figure 1G ), but the modulation was less robust for the GluR2 flip isoform and the currents evoked by 1000 mM glutamate were still larger than those evoked by 5 mM glutamate ( Figure 1G) . Interestingly, the size of the reduction in current amplitudes at high glutamate concentrations was larger for flop splice isoforms than for the corresponding flip isoforms for both GluR1 and GluR2 receptors ( Figures 1D, 1G, 2B, and 2C) . In cerebellar granule cell neurons, where the expression of flip and flop isoforms varies during early postnatal development (Mosbacher et al., 1994) , the ratio of steady-state currents evoked by 1000 mM and 50 mM glutamate were smallest in cells in which PEPA (a drug that selectively potentiates glutamate-evoked currents for flop GluR isoforms) resulted in the largest enhancement of glutamate-evoked responses. Importantly, all AMPA receptor subunits and heteromers are modulated by stargazin in a glutamate-dependent and calcium independent manner, albeit to different extents.
The Mechanism Underlying the Bell-Shaped Concentration-Response Curves Bell-shaped concentration-response curves have also been reported for acetylcholine receptors (Colquhoun and Ogden, 1988; Giniatullin et al., 2005) . Both the peak amplitude and the steady state current of acetylcholine receptors decline at millimolar concentrations of acetylcholine, and this ''fall-off'' has been explained as an effect of acetylcholine as an open channel blocker at high concentrations or by preferential occupancy of different desensitization states of the receptor at low and high agonist concentrations (Colquhoun and Ogden, 1988; Giniatullin et al., 2005) .
It was suggested that similar reductions in AMPA-receptor peak currents at near-saturating glutamate concentrations might reflect glutamate binding to divalent cations and subsequent open channel block by the chaotropic species (Raman and Trussell, 1992) . However, the steady-state current of AMPA receptors declines in the micromolar range ( Figure 4C ) (Raman and Trussell, 1992; Vlachova et al., 1987) , making it unlikely that the reductions result from open channel block. Bell-shaped concentration-response curves were also observed for steadystate currents of native kainate receptors and were explained by the different concentration dependence of activation and desensitization (Paternain et al., 1998) .
Our results suggest that stargazin dissociates from AMPA receptors within milliseconds after receptor desensitization. With the exception of the size of steady-state currents, the GluR1-stargazin tandem protein and GluR1/stargazin complexes showed no difference in receptor properties, including rise time and peak open probability, or deactivation and desensitization kinetics. Because the effect of stargazin to slow the rate at which AMPA receptors desensitize (Chen et al., 2000; Kott et al., 2007; Priel et al., 2005; Tomita et al., 2004 Tomita et al., , 2005a Turetsky et al., 2005; Yamazaki et al., 2004) was unaltered in the tandem receptors, we conclude that dissociation of stargazin from AMPA receptors occurs after desensitization. Further support for this conclusion is provided by our results at low glutamate concentrations for GluR4i (Figures 6E and 6F) and from comparisons of the relative amplitudes of the currents evoked by 1000 mM and 5 mM glutamate with and without stargazin for GluR flip and flop isoforms in the absence and presence of cyclothiazide. Cyclothiazide reduced stargazin mediated concentration-dependent modulation of the GluR1 flip isoform, but not the GluR1i flop isoform ( Figure S4 ).
We suggest that in resting and open channel states, the majority of receptors have stargazin associated with them, but the equilibrium between stargazin-coupled and stargazinuncoupled forms of the receptor shifts toward the stargazinuncoupled form once the receptors desensitize ( Figure S5 ). An estimate of the fraction of desensitized receptors still functionally coupled with stargazin can be made from the amplitudes (relative to the peak currents) of the steady-state responses at 10 mM glutamate for GluR1i alone, GluR1i with stargazin, and the GluR1i-stargazin tandem receptor, which were about 0.3%, 4%, and 8%, respectively. These relative amplitudes indicate that roughly half of the receptors contributing to the steadystate currents at near-saturating glutamate have stargazin associated with them. Since stargazin increases the rate of recovery from desensitization, stargazin-coupled receptors will recover more often and contribute more to the steady-state current. Assuming that re-association of stargazin with the receptors is minimal before the receptors once again desensitize, simulations using the simple kinetic mechanism in Figure S5 suggest that about two-thirds of desensitized receptors are no longer effectively coupled to stargazin. What fraction of the total receptor population have stargazin associated with them will depend on the fraction of the receptors desensitized at steady-state, which will increase with glutamate concentration. As a larger fraction of receptors occupy desensitized states as the concentration of glutamate is increased, a larger fraction of the receptors contributing to the steady-state responses will no longer be effectively coupled with stargazin and stargazin enhancement of receptor gating will be increasingly reduced.
The Kinetics of Stargazin Dissociation from AMPA Receptors
Previous studies have demonstrated that the first extracellular loop of stargazin slows desensitization and deactivation of AMPA receptors and controls EPSC decay in neurons (Cho et al., 2007; Milstein et al., 2007; Tomita et al., 2005a) . Our results indicate that concentration-dependent modulation of AMPA receptors occurs just after they desensitize. The kinetics of the difference current obtained from the GluR1-stargazin tandem protein and the GluR1/stargazin complex ( Figure 6C ), and the corresponding results for the GluR4-stargazin tandem ( Figure S3C ), suggest that stargazin-receptor interactions disengage within milliseconds. Our oocyte studies indicate that stargazin modulation is re-acquired within 1 s ( Figure 1C ). It seems unlikely that two large multidomain membrane proteins would completely dissociate from each other on this time scale. It is possible, however, that a small number of key functional interactions responsible for stargazin modulation of gating are lost initially as a result of conformational changes associated with desensitization. Our biochemical data in oocytes ( Figure 4B) show that prolonged exposure to high concentrations of glutamate completely dissociates stargazin. It is possible that brief applications of glutamate induce rapid and reversible uncoupling of stargazin modulation, whereas prolonged applications of glutamate may result in the complete dissociation and re-distribution of receptors. Indeed, we have previously reported that application of AMPA to neurons for 1 min induces the internalization of AMPA receptors, but not stargazin (Tomita et al., 2004) . Recently, a contribution of AMPA receptor desensitization to distribution of in moving AMPA receptors at synapses was reported (Heine et al., 2008) and our study indicates that AMPA receptor-desensitization dependent trafficking may be influenced by dynamic regulation of TARP/AMPA receptor interactions.
We identified the cytoplasmic domain of the AMPA receptor as a critical region for the dissociation of AMPA receptors from stargazin. It remains unclear, however, how glutamate binding to the extracellular domain of AMPA receptors results in the dissociation of stargazin and AMPA receptors through the cytoplasmic domains of AMPA receptors. Agonist binding to extracellular domains of other receptors, for example receptor tyrosine kinases or G protein coupled receptors, can result in phosphorylation of intracellular residues or the activation of cytoplasmic factors. Whether similar cytoplasmic signaling events contribute to glutamate-induced dissociation of stargazin requires further investigation.
AMPA Receptor Structure and Stargazin Dissociation
The structure of the ligand-binding domain (S1-S2) of AMPA receptors in complex with various agonists and drugs has been resolved at the atomic level, and it has been shown that closure of the S1-S2 binding cleft results in the opening of the receptor channels and that desensitization is associated with rearrangements at the dimer interface (Armstrong et al., 2006; Gouaux, 2004; Mayer and Armstrong, 2004) . Previous studies from our laboratory showed that stargazin interacts with the extracellular glutamate-binding domain of AMPA receptors (Tomita et al., 2007b) . Interestingly, chimeras in which the ligandbinding domain (S1-S2) of the GluR1 flop AMPA receptor were replaced with the GluR6 kainate receptor showed even greater loss of stargazin modulation of steady-state currents at high glutamate concentrations ( Figure 3A) , underscoring the importance of the ligand binding domain for the effects reported here and supporting the idea that structural changes in the ligand-binding domain contribute to stargazin dissociation from AMPA receptors.
The number of stargazin molecules that bind to each receptor, and the number that must dissociate to lose effects on gating, are unknown. The GluR1-stargazin tandem protein forms functional AMPA receptors, suggesting that the stoichiometry is 1:1. However, some stargazin molecules in GluR1-stargazin tandem proteins may not be functionally incorporated into active receptors. Regardless, this GluR1-stargazin tandem protein might be useful for studying the structure of AMPA receptor/stargazin complexes.
Functional Implications of Receptor Autoinactivation
The dynamic nature of stargazin regulation of AMPA receptor function may allow stargazin to play a central role in short-term modulation of neuronal function. Our results in hippocampal neurons demonstrate that the dissociation of stargazin can contribute to paired pulse depression. The size of this effect would be expected to depend on presynaptic firing frequencies and the kinetics of stargazin dissociation and reassociation in neurons. Although steady-state currents do not contribute to synaptic transmission, they are responsible for the excitotoxicity that occurs when ambient levels of glutamate are elevated. The dissociation of stargazin that accompanies desensitization of the receptors at glutamate concentrations in the low micromolar range may be a mechanism to protect neurons from excitotoxic damage.
EXPERIMENTAL PROCEDURES Antibodies
The following antibodies were used: rabbit polyclonal antibodies to stargazin and pan-TARP , GluR1, GluR2/3, GluR4, and GluR6/7 (Millipore), rat monoclonal antibody to HA epitope (Roche).
Plasmid Construction
Using the chimeric primers for GluR1 and GluR6, mutated PCR fragments were subcloned using appropriate restriction enzymes or standard overlap PCR methods (Tomita et al., 2005a) . All DNA constructs were verified by sequencing.
Electrophysiology Using Xenopus laevis Oocytes
Two electrode voltage clamp recordings were performed as described (Tomita et al., 2004) . Briefly, cRNAs were transcribed in vitro using the T7 mMessage mMachine kit (Ambion) and injected at the indicated amounts into defolliculated Xenopus laevis oocytes. Two-electrode voltage-clamp analysis (E h = À70 mV) was carried out 2-3 days postinjection at room temperature. Each agonist was bath applied in recording solution (90 mM NaCl, 1.0 mM KCl, 1.5 mM CaCl 2 , and 10 mM HEPES [pH = 7.4]).
Surface Labeling of Oocytes
Surface labeling was performed as described (Tomita et al., 2005a) . Briefly, 3 days after injection, oocytes were incubated for 1 hr with 0.25 mg/ml rat anti-HA antibody (3F10, Roche) followed by a 30 min incubation with HRP conjugated anti-rat Ig. Individual oocytes were then placed into 100 ml SuperSignal ELISA Femto Maximum Sensitivity Substrate (Pierce) and chemiluminescence was quantified using a Veritas Microplate Luminometer (Turner Biosystems). Oocytes were treated with glutamate (1 mM) for 10 min. Glutamate was present in all experimental procedures except for the chemiluminescence reaction.
Immunoprecipitation
For coimmunoprecipitations , oocyte membranes were suspended in lysis buffer containing TEEN (25 mM Tris-Cl [pH 7.4], 1 mM EDTA, 1 mM EGTA, 150 mM NaCl), 1% Triton X-100, protease inhibitors (1 mM PMSF, 10 mg/ml leupeptin) and centrifuged at 37,000 3 g for 40 min. The supernatants were then incubated with 3 mg of affinity-purified antibodies and 20 ml of protein A sepharose beads. The beads were then washed three times with 1% Triton in TEEN. For some experiments, glutamate or CNQX were added for 20 min at 4 C and washed once with 1% Triton X-100 in TEEN. Bound proteins were eluted by heating the resin in 20 ml of 1X SDS-PAGE sample buffer and analyzed by SDS-PAGE.
Patch-Clamp Recording
Whole-cell recordings from cerebellar granule cells and recordings from outside-out patches from transfected tsA201 cells were performed as previously described (Cho et al., 2007; Robert and Howe, 2003) . Low-density hippocampal neuron cultures (6 3 10 4 /cm 2 ) were maintained as described (Tomita et al., 2005b) and transfected with cDNA encoding eGFP (0.2 mg), GluR4 + stargazin (1 mg), or GluR4-stargazin tandem (1 mg) at DIV 8 with calcium phosphate. Paired-recording was performed at 10-12 DIV with two EPC 9 amplifiers (HEKA) in external solution containing (in mM): 10 HEPES, 140 NaCl, 2.5 KCl, 2.5 CaCl 2 , 1.3 MgSO 4 , 2.7 MgCl 2 , and 10 glucose. Patch pipettes (tip resistance 6-8 MU) were filled with recording solution that contained (in mM): 130 cesium methanesulfonate, 5 HEPES, 5 Mg-ATP, 0.2 Na-GTP, 20 TEA and 5 EGTA, and all recordings were performed at room temperature. To isolate AMPA receptor-mediated EPSCs, AP-5 (50 mM) and picrotoxin (100 mM) were added to the external solution. To confirm the EPSCs were AMPA-receptor mediated, 100mM CNQX was applied to the bath solution after each recording. To record evoked EPSCs, isolated cell pairs were selected and patched simultaneously in the whole-cell mode. Both cells were voltage clamped at À70 mV. Two voltage jumps (to +20 mV for 1ms) were applied at a 20 ms interval to a neuron (presynaptic cell), and the EPSC in the other neuron (postsynaptic cell) was recorded. Currents were analog low-pass filtered at 3 kHz and digitally sampled at 40 kHz. For each cell pair, 25 events at 0.2 Hz were recorded and averaged for analysis. Mice were obtained from Jackson Laboratory and maintained at the Yale animal facility under the guidelines of the Institutional Animal Care and Use Committee.
Fitting and Calculation of Concentration-Response Curves
For the results presented in Figure 5 , concentration-response curves of AMPA receptors alone was fitted to fðxÞ = 1 À 1= À 1 + À 10^Àlog 10 ½mM À log 10 ½EC 50 ÁÁÁ :
The fits to the results gave an EC 50 of 10 mM and a Hill coefficient of 1. Because stargazin enhanced AMPA receptor function roughly 4-fold (Tomita et al., 2005a) and decreases the EC 50 to 2 mM (Kott et al., 2007; Priel et al., 2005; Tomita et al., 2005a; Turetsky et al., 2005; Yamazaki et al., 2004) , the concentration-response curve of AMPA receptors with stargazin was fitted to: 4f 0 ðxÞ = 4 3 À 1 À 1= À 1 + À 10^Àlog 10 ½mM À log 10 ½EC 50 ÁÁÁÁ :
The dissociation curve of AMPA receptors from stargazin was fitted to: FðxÞ = 1= À 1 + À 10^Àlog 10 ½mM À log 10 ½IC 50 ÁÁÁ :
The fits to the results gave an IC 50 was 16 mM. The total evoked current from cells expressing AMPA receptors with stargazin was calculated as the sum of curves for AMPA receptors with and without stargazin, where each curve was weighted by the proportion of each channel type estimated from the fit to the dissociation curve: Total = FðxÞ 3 4f 0 ðxÞ + ð1 À FðxÞÞ 3 fðxÞ All concentration-response curves were normalized to the size of the response at 1000 mM glutamate.
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